Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome

Cover Page

Cite item

Full Text

Abstract

Evaluation of bone marrow cytogenetic abnormalities in myelodysplastic syndrome is of great importance for confirming the clonal disease nature, determining the prognosis and choosing treatment tactics. Cytogenetic abnormalities are detected in 40–70 % of patients with myelodysplastic syndrome, and the variety of these abnormalities reflects the disease characteristics.

This article describes the clinical follow-up of a patient with a myelodysplastic neoplasia with blast excess 1 and trisomy of chromosome 14.

About the authors

M. N. Pautova

I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia

Author for correspondence.
Email: paytova.marinaa@gmail.com
ORCID iD: 0009-0004-7215-791X

Marina N. Pautova 

41 Kirochnaya St., Saint Petersburg 191015

Russian Federation

L. E. Koloskova

Medical Laboratory SPb

ORCID iD: 0000-0002-5221-8832

71A Obukhovskoy Oborony Prospekt, Saint Petersburg 192029

Russian Federation

O. I. Filippova

I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia

ORCID iD: 0000-0001-8142-5278

41 Kirochnaya St., Saint Petersburg 191015

Russian Federation

A. V. Koloskov

I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia

ORCID iD: 0000-0002-5249-4255

41 Kirochnaya St., Saint Petersburg 191015

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.